Regular Article
How can the risk of long-term consequences of rheumatoid arthritis be reduced?

https://doi.org/10.1053/berh.2000.0131Get rights and content

Abstract

The long-term natural history of rheumatoid arthritis includes early radiographic damage and progression, severe functional declines, work disability and increased mortality rates. Emerging evidence suggests that this natural history may be favourably affected by disease-modifying anti-rheumatic drugs (DMARDs), which slow the radiographic progression and functional decline. It is necessary to document both the efficacy of these drugs in randomized controlled clinical trials and their long-term effectiveness in clinical observational studies. Although a 20% improvement in inflammatory measures in the American College of Rheumatology Core Data Set (ACR20) distinguishes DMARDs from placebo in clinical trials, it is not clear that a control of inflammation at this level, or even at 50%, is sufficient to prevent long-term damage. There is limited financial support for long-term observational studies, which depend on data from the clinical experience of rheumatologists. Quantitative databases from clinical care, can be developed to document long-term outcomes in patients with early rheumatoid arthritis to include additional physical, radiographic, laboratory and patient questionnaire quantitative data. Patient self-report questionnaires appear to provide the least expensive and most effective measures toward this goal.

References (208)

  • K Kaarela et al.

    Continuous progression of radiological destruction in seropositive rheumatoid arthritis

    Journal of Rheumatology

    (1997)
  • E Yelin et al.

    Work disability in rheumatoid arthritis: effects of disease, social, and work factors

    Annals of Internal Medicine

    (1980)
  • GL Makisara et al.

    Prognosis of functional capacity and work capacity in rheumatoid arthritis

    Clinical Rheumatology

    (1982)
  • S Cobb et al.

    Length of life and cause of death in rheumatoid arthritis

    New England Journal of Medicine

    (1953)
  • HA Isomaki et al.

    Death rate and causes of death in patients with rheumatoid arthritis

    Scandinavian Journal of Rheumatology

    (1975)
  • MJ Lichtenstein et al.

    Rheumatoid arthritis identified in population based cross sectional studies: low prevalence of rheumatoid factor

    Journal of Rheumatology

    (1991)
  • WM Mikkelsen et al.

    A four year follow-up of suspected rheumatoid arthritis: the Tecumseh, Michigan, Community Health Study

    Arthritis and Rheumatism

    (1969)
  • JB O'Sullivan et al.

    The prevalence of rheumatoid arthritis: follow-up evaluation of the effect of criteria on rates in Sudbury, Massachusetts

    Annals of Internal Medicine

    (1972)
  • T Pincus et al.

    How many types of patients meet classification criteria for RA?

    Journal of Rheumatology

    (1994)
  • CL Short et al.

    The course of rheumatoid arthritis in patients receiving simple medical and orthopedic measures

    New England Journal of Medicine

    (1948)
  • T Pincus et al.

    Why randomized controlled clinical trials do not depict accurately long-term outcomes in rheumatoid arthritis: some explanations and suggestions for future studies

    Clinical and Experimental Rheumatology

    (1997)
  • F Wolfe et al.

    Termination of slow acting anti-rheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts

    Journal of Rheumatology

    (1990)
  • T Pincus et al.

    Long-term drug therapy for rheumatoid arthritis in seven rheumatology private practices. I. Nonsteroidal anti-inflammatory drugs

    Journal of Rheumatology

    (1992)
  • T Pincus et al.

    Long-term drug therapy for rheumatoid arthritis in seven rheumatology private practices. II. Second-line drugs and prednisone

    Journal of Rheumatology

    (1992)
  • TM Sokka et al.

    A retrospective study of treating RA patients with various combinations of slow-acting antirheumatic drugs in a county hospital

    Scandinavian Journal of Rheumatology

    (1997)
  • DJ Hawley et al.

    Use of combination therapy in the routine care of patients with rheumatoid arthritis: physician and patient surveys

    Clinical and Experimental Rheumatology

    (1999)
  • T Pincus

    Improved outcomes over 6·6 years in rheumatoid arthritis (RA) with aggressive drug therapies—methotrexate in 86%, prednisone in 93%, combination disease-modifying antirheumatic drugs (DMARDs) in 39%

    Arthritis and Rheumatism

    (1999)
  • T Pincus et al.

    ‘No evidence of disease’ in rheumatoid arthritis using methotrexate in combination with other drugs: a contemporary goal for rheumatology care?

    Clinical and Experimental Rheumatology

    (1997)
  • P Emery et al.

    Early rheumatoid arthritis: time to aim for remission?

    Annals of the Rheumatic Diseases

    (1995)
  • ME Weinblatt

    Rheumatoid arthritis: treat now, not later!

    Annals of Internal Medicine

    (1996)
  • JM Cruickshank et al.

    Low mortality from all causes, including myocardial infarction, in well-controlled hypertensives treated with a beta-blocker plus other antihypertensives

    Journal of Hypertension

    (1987)
  • AK Trocha et al.

    Effects of intensified antihypertensive treatment in diabetic nephropathy: mortality and morbidity results of a prospective controlled 10-year study

    Journal of Hypertension

    (1999)
  • K Lehtinen et al.

    Intramuscular gold therapy is associated with long survival in patients with rheumatoid arthritis

    Journal of Rheumatology

    (1991)
  • F Wolfe et al.

    Methotrexate alters the course of rheumatoid arthritis (RA): increased survival of methotrexate treated RA patients: a 25-year study of 1842 patients (ACR Plenary Session)

    Arthritis and Rheumatism

    (1998)
  • D Krause et al.

    Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis

    Arthritis and Rheumatism

    (2000)
  • T Pincus et al.

    Does partial control of inflammation prevent long-term joint damage: clinical rationale for combination therapy with multiple disease-modifying antirheumatic drugs

    Clinical and Experimental Rheumatology

    (1999)
  • F Wolfe et al.

    The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: a study of 1141 patients

    Journal of Rheumatology

    (1993)
  • AB Corrigan et al.

    Benign rheumatoid arthritis of the aged

    British Medical Journal

    (1974)
  • LA Healey et al.

    The relation of polymyalgia rheumatica to rheumatoid arthritis

    Journal of Rheumatology

    (1988)
  • K Granfors et al.

    Yersinia antigens in synovial-fluid cells from patients with reactive arthritis

    New England Journal of Medicine

    (1989)
  • B Harrison et al.

    Inflammatory polyarthritis in the community is not a benign disease: predicting functional disability one year after presentation

    Journal of Rheumatology

    (1996)
  • T Pincus et al.

    Updating a reassessment of traditional paradigms concerning rheumatoid arthritis

  • I Kushner

    Does aggressive therapy of rheumatoid arthritis affect outcome

    Journal of Rheumatology

    (1989)
  • AK Thould et al.

    Assessment of radiological changes in the hands and feet in rheumatoid arthritis: their correlation with prognosis

    Annals of the Rheumatic Diseases

    (1966)
  • A Brook et al.

    Radiographic changes in early rheumatoid disease

    Annals of the Rheumatic Diseases

    (1977)
  • HA Fuchs et al.

    Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease

    Journal of Rheumatology

    (1989)
  • HA Fuchs et al.

    Radiographic damage in rheumatoid arthritis: description by nonlinear models

    Journal of Rheumatology

    (1992)
  • A Larsen et al.

    Hand radiography of 200 patients with rheumatoid arthritis repeated after an interval of one year

    Scandinavian Journal of Rheumatology

    (1987)
  • M Lassere et al.

    Reference curves of radiographic damage in patients with rheumatoid arthritis: application of quantile regression and fractional polynomials

    Journal of Rheumatology

    (1997)
  • F Salaffi et al.

    Progress of the anatomical damage in rheumatoid hands. Radiography of the natural course of the disease or of the course during treatment?

    Scandinavian Journal of Rheumatology

    (1989)
  • Cited by (0)

    View full text